Replies to post #12060 on Generex Biotechnology Corp. (fka GNBTQ)

[nroodt]

However I do not think Generex is fully aware of the complications of this. When this clearing house, which according to my broker (who did not tell the name), is one of the biggest with international clients, than there must be many people like me in several countries that are now not able to buy Generex any more. That must be a shorters dream. And the blockade is only for Generex, I did some test orders for real cannabis companies, and they were all accepted. Even the one for ICC International Cannabis OTC.

[WeeZuhl]

Generex themselves emailed me to confirm they were not cannabis related.

LOL. I have an appointment, so I can't keep doing this. But I could keep doing this. LOL.



https://www.businesswire.com/news/home/20181126005204/en/Generex-Announces-NuGenerex-HydroHealth-CBD-High-Alkaline

Generex Announces NuGenerex HydroHealth CBD High Alkaline Health Water As First Target Product In Planned Line Of CBD Therapies

November 26, 2018 09:00 AM Eastern Standard Time
MIRAMAR, Fla.--(BUSINESS WIRE)--Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (www.otcmarkets.com/stock/GNBT/quote) today announced an agreement with Puration, Inc. (USOTC: PURA) to develop and produce NuGenerex CBD HydroHealth High Alkaline Water. The CBD used in the NuGenerex CBD HydroHealth product line will be exclusively derived from industrial hemp using a patented extraction process that yields ultra-purified and characterized CBD formulations.

....

“Subject to testing and corresponding regulatory approvals, we’re targeting a million-bottle launch of Generex CBD HydroHealth Water in 2019,” said Joseph Moscato, Generex President & Chief Executive Officer. “Given the network of pharmacies Generex owns itself, we are confident we can achieve if not exceed our million-bottle launch target. Puration’s experience and the caliber of Puration’s underlying extraction technology combined with the recently updated production facilities of Puration’s co-packer, are instrumental in Generex’s plan to rapidly launch NuGenerex CBD HydroHealth Water.”

“We are especially excited about Puration’s patented extraction technology that enables us to explicitly define and characterize the CBD and cannabinoid content of hemp extracts to develop proprietary, patented formulations for NuGenerex,” said Jason Terrell, MD, Chief Medical and Scientific Officer of Generex. “Through NuGenerex Distribution Solutions, we have the consumer connections, technology, and HIPAA compliant systems that will enable us to compile real world evidence on the safety and effectiveness of our NuGenerex CBD products for health maintenance in a variety of chronic conditions.”